Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-12-31 Purchase | 2022-01-04 08:51 am | REATA PHARMACEUTICALS INC | RETA | Soni Manmeet Singh CFO COO | 16,000 | $26.22 | $419,565 | 19,000 (Direct) | View |
| 2021-06-14 Sale | 2021-06-16 4:04 pm | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Research Officer | 60,000 | $142.58 | $8,554,906 | 532,419 (Direct) | View |
| 2021-06-07 Sale | 2021-06-09 4:28 pm | REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine CAO | 10,000 | $142.65 | $1,426,513 | 52,868 (Direct) | View |
| 2021-05-26 Sale | 2021-05-27 6:15 pm | REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine CAO | 10,000 | $124.55 | $1,245,470 | 47,414 (Direct) | View |
| 2020-11-16 Sale | 2020-11-18 4:19 pm | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Research Officer | 25,000 | $169.57 | $4,239,148 | 519,783 (Direct) | View |
| 2020-11-12 Sale | 2020-11-13 3:53 pm | REATA PHARMACEUTICALS INC | RETA | McClellan William D. Jr. Director | 4,000 | $172.92 | $691,669 | 6,000 (Direct) | View |
| 2020-11-12 Sale | 2020-11-13 3:44 pm | REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine CAO | 3,500 | $176.02 | $616,070 | 21,580 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-02-07 Ownership | 2022-02-07 4:18 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Loewen Andrea VP | 0 | $0 | 103,106 (Direct) | View |
| 2022-02-07 Ownership | 2022-02-07 4:11 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Khan Samina SVP Chief Medical Officer | 0 | $0 | 115,249 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 5:22 pm | N/A 2032-01-03 | REATA PHARMACEUTICALS INC | RETA | McGaughy R Kent Jr Director 10% Owner | 399 | $16.14 | 399 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 4:10 pm | N/A 2032-01-03 | REATA PHARMACEUTICALS INC | RETA | Anand Bhaskar CAO | 37,500 | $0 | 41,500 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 4:09 pm | N/A 2032-01-03 | REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer | 105,000 | $0 | 105,000 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 4:08 pm | N/A 2032-01-03 | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Research Officer | 105,000 | $0 | 122,000 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 4:07 pm | N/A 2032-01-03 | REATA PHARMACEUTICALS INC | RETA | Soni Manmeet Singh CFO COO | 150,000 | $0 | 169,000 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 4:06 pm | N/A 2032-01-03 | REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer | 105,000 | $0 | 105,000 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 4:04 pm | N/A 2032-01-03 | REATA PHARMACEUTICALS INC | RETA | Ruff Shamim Director | 199 | $16.14 | 317 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 4:04 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Ruff Shamim Director | 118 | $27.32 | 317 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 4:03 pm | N/A 2032-01-03 | REATA PHARMACEUTICALS INC | RETA | McClellan William D. Jr. Director | 99 | $16.14 | 158 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 4:03 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | McClellan William D. Jr. Director | 59 | $27.32 | 158 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 4:02 pm | N/A 2032-01-03 | REATA PHARMACEUTICALS INC | RETA | Edwards Martin Director | 99 | $16.14 | 158 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 4:02 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Edwards Martin Director | 59 | $27.32 | 158 (Direct) | View |
| 2021-11-13 Ownership | 2021-11-15 10:16 am | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Anand Bhaskar CAO | 0 | $0 | 19,000 (Direct) | View |
| 2021-06-14 Conversion | 2021-06-16 4:04 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Research Officer | 5,000 | $0 | 532,419 (Direct) | View |
| 2021-06-14 Exercise | 2021-06-16 4:04 pm | N/A 2023-06-15 | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Research Officer | 19,525 | $0 | 532,419 (Direct) | View |
| 2021-06-14 Exercise | 2021-06-16 4:04 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Research Officer | 19,525 | $11.62 | 532,419 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 5:25 pm | N/A 2031-06-10 | REATA PHARMACEUTICALS INC | RETA | McGaughy R Kent Jr Director 10% Owner | 690 | $83.24 | 5,690 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 5:25 pm | N/A 2031-06-10 | REATA PHARMACEUTICALS INC | RETA | McGaughy R Kent Jr Director 10% Owner | 5,000 | $0 | 5,690 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 4:11 pm | N/A 2031-06-10 | REATA PHARMACEUTICALS INC | RETA | Edwards Martin Director | 5,000 | $0 | 5,000 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 4:05 pm | N/A 2031-06-10 | REATA PHARMACEUTICALS INC | RETA | ROSE WILLIAM Director 10% Owner | 810 | $83.24 | 5,810 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 4:05 pm | N/A 2031-06-10 | REATA PHARMACEUTICALS INC | RETA | ROSE WILLIAM Director 10% Owner | 5,000 | $0 | 5,810 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 11:33 am | N/A 2031-06-10 | REATA PHARMACEUTICALS INC | RETA | Ruff Shamim Director | 780 | $83.24 | 5,780 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 11:33 am | N/A 2031-06-10 | REATA PHARMACEUTICALS INC | RETA | Ruff Shamim Director | 5,000 | $0 | 5,780 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 11:29 am | N/A 2031-06-10 | REATA PHARMACEUTICALS INC | RETA | Oliger Christy J. Director | 180 | $83.24 | 5,180 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 11:29 am | N/A 2031-06-10 | REATA PHARMACEUTICALS INC | RETA | Oliger Christy J. Director | 5,000 | $0 | 5,180 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 11:26 am | N/A 2031-06-10 | REATA PHARMACEUTICALS INC | RETA | Nielsen Jack Director | 1,201 | $83.24 | 6,201 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 11:26 am | N/A 2031-06-10 | REATA PHARMACEUTICALS INC | RETA | Nielsen Jack Director | 5,000 | $0 | 6,201 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 11:21 am | N/A 2031-06-10 | REATA PHARMACEUTICALS INC | RETA | McClellan William D. Jr. Director | 5,000 | $0 | 5,000 (Direct) | View |
| 2021-06-07 Conversion | 2021-06-09 4:28 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine CAO | 10,000 | $0 | 52,868 (Direct) | View |
| 2021-06-07 Exercise | 2021-06-09 4:28 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine CAO | 10,000 | $22.57 | 52,868 (Direct) | View |
| 2021-06-07 Exercise | 2021-06-09 4:28 pm | N/A 2026-12-07 | REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine CAO | 10,000 | $0 | 52,868 (Direct) | View |
| 2021-05-26 Conversion | 2021-05-27 6:15 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine CAO | 10,000 | $0 | 47,414 (Direct) | View |
| 2021-05-26 Exercise | 2021-05-27 6:15 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine CAO | 7,066 | $22.57 | 47,414 (Direct) | View |
| 2021-05-26 Exercise | 2021-05-27 6:15 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine CAO | 2,934 | $11 | 47,414 (Direct) | View |
| 2021-05-26 Exercise | 2021-05-27 6:15 pm | N/A 2026-05-25 | REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine CAO | 10,000 | $0 | 47,414 (Direct) | View |
| 2021-04-15 Option Award | 2021-04-16 1:38 pm | N/A 2031-04-15 | REATA PHARMACEUTICALS INC | RETA | Ruff Shamim Director | 319 | $52.85 | 11,569 (Direct) | View |
| 2021-04-15 Option Award | 2021-04-16 1:38 pm | N/A 2031-04-15 | REATA PHARMACEUTICALS INC | RETA | Ruff Shamim Director | 11,250 | $0 | 11,569 (Direct) | View |
| 2021-04-15 Option Award | 2021-04-16 1:34 pm | N/A 2031-04-15 | REATA PHARMACEUTICALS INC | RETA | Oliger Christy J. Director | 106 | $52.85 | 11,356 (Direct) | View |
| 2021-04-15 Option Award | 2021-04-16 1:34 pm | N/A 2031-04-15 | REATA PHARMACEUTICALS INC | RETA | Oliger Christy J. Director | 11,250 | $0 | 11,356 (Direct) | View |
| 2020-12-31 Ownership | 2021-01-06 5:14 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Huff James Warren CEO | 270,000 | $0 | 2,036,748 (Direct) | View |
| 2020-12-31 Ownership | 2021-01-06 5:14 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Huff James Warren CEO | 0 | $0 | 2,036,748 (Indirect) | View |
| 2021-01-04 Option Award | 2021-01-06 4:52 pm | N/A 2031-01-04 | REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer | 16,500 | $0 | 16,500 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:43 pm | N/A 2031-01-04 | REATA PHARMACEUTICALS INC | RETA | Soni Manmeet Singh CFO COO | 24,000 | $0 | 24,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:40 pm | N/A 2031-01-04 | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Research Officer | 24,000 | $0 | 24,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:38 pm | N/A 2031-01-04 | REATA PHARMACEUTICALS INC | RETA | Huff James Warren CEO | 44,600 | $0 | 1,505,542 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:13 pm | N/A 2031-01-04 | REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine CAO | 8,000 | $0 | 8,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:10 pm | N/A 2031-01-04 | REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer | 16,500 | $0 | 16,500 (Direct) | View |
| 2020-12-23 Other | 2020-12-29 5:42 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | McGaughy R Kent Jr Director 10% Owner | 166,666 | $0 | 3,126,659 (Indirect) | View |
| 2020-12-23 Other | 2020-12-29 5:35 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | CPMG Inc Director 10% Owner | 166,666 | $0 | 3,063,567 (Indirect) | View |
| 2020-11-18 Gift | 2020-11-19 4:08 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine CAO | 600 | $0 | 14,546 (Direct) | View |
| 2020-11-16 Conversion | 2020-11-18 4:19 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Research Officer | 25,000 | $0 | 519,783 (Direct) | View |
| 2020-11-16 Exercise | 2020-11-18 4:19 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Research Officer | 25,000 | $11 | 519,783 (Direct) | View |
| 2020-11-16 Exercise | 2020-11-18 4:19 pm | N/A 2026-05-25 | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Research Officer | 25,000 | $0 | 519,783 (Direct) | View |
| 2020-11-12 Conversion | 2020-11-13 3:53 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | McClellan William D. Jr. Director | 4,000 | $0 | 6,000 (Direct) | View |
| 2020-11-12 Exercise | 2020-11-13 3:53 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | McClellan William D. Jr. Director | 4,000 | $25.52 | 6,000 (Direct) | View |
| 2020-11-12 Exercise | 2020-11-13 3:53 pm | N/A 2027-06-14 | REATA PHARMACEUTICALS INC | RETA | McClellan William D. Jr. Director | 4,000 | $0 | 6,000 (Direct) | View |
| 2020-11-12 Conversion | 2020-11-13 3:44 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine CAO | 3,500 | $0 | 21,580 (Direct) | View |
| 2020-11-12 Exercise | 2020-11-13 3:44 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine CAO | 3,500 | $11 | 21,580 (Direct) | View |
| 2020-11-12 Exercise | 2020-11-13 3:44 pm | N/A 2026-05-25 | REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine CAO | 3,500 | $0 | 21,580 (Direct) | View |